CANF
Price
$1.02
Change
-$0.02 (-1.92%)
Updated
Jul 2, 04:58 PM (EDT)
Capitalization
13.76M
IPSC
Price
$0.56
Change
+$0.02 (+3.70%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
47.39M
36 days until earnings call
Interact to see
Advertisement

CANF vs IPSC

Header iconCANF vs IPSC Comparison
Open Charts CANF vs IPSCBanner chart's image
Can-Fite BioPharma
Price$1.02
Change-$0.02 (-1.92%)
Volume$300
Capitalization13.76M
Century Therapeutics
Price$0.56
Change+$0.02 (+3.70%)
Volume$3.36K
Capitalization47.39M
CANF vs IPSC Comparison Chart in %
Loading...
CANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CANF vs. IPSC commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANF is a Hold and IPSC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (CANF: $1.03 vs. IPSC: $0.56)
Brand notoriety: CANF and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CANF: 50% vs. IPSC: 38%
Market capitalization -- CANF: $13.76M vs. IPSC: $47.39M
CANF [@Biotechnology] is valued at $13.76M. IPSC’s [@Biotechnology] market capitalization is $47.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANF’s FA Score shows that 0 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • CANF’s FA Score: 0 green, 5 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, CANF is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANF’s TA Score shows that 3 TA indicator(s) are bullish while IPSC’s TA Score has 4 bullish TA indicator(s).

  • CANF’s TA Score: 3 bullish, 4 bearish.
  • IPSC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CANF and IPSC are a bad buy in the short-term.

Price Growth

CANF (@Biotechnology) experienced а -2.83% price change this week, while IPSC (@Biotechnology) price change was -2.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +33.16%, and the average quarterly price growth was +1.56%.

Reported Earning Dates

CANF is expected to report earnings on Apr 14, 2025.

IPSC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPSC($47.4M) has a higher market cap than CANF($13.8M). CANF YTD gains are higher at: -36.615 vs. IPSC (-45.050). IPSC has higher annual earnings (EBITDA): -5.99M vs. CANF (-7.79M). IPSC has more cash in the bank: 165M vs. CANF (4.73M). CANF has less debt than IPSC: CANF (57K) vs IPSC (52.7M). IPSC has higher revenues than CANF: IPSC (115M) vs CANF (667K).
CANFIPSCCANF / IPSC
Capitalization13.8M47.4M29%
EBITDA-7.79M-5.99M130%
Gain YTD-36.615-45.05081%
P/E RatioN/AN/A-
Revenue667K115M1%
Total Cash4.73M165M3%
Total Debt57K52.7M0%
FUNDAMENTALS RATINGS
CANF: Fundamental Ratings
CANF
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CANFIPSC
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USEA1.540.06
+4.05%
United Maritime Corp
ASTL7.120.21
+3.00%
Algoma Steel Group
MOLN3.760.05
+1.35%
Molecular Partners AG
BHF53.78N/A
N/A
Brighthouse Financial
DTE130.68-1.75
-1.32%
DTE Energy Company

CANF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CANF has been loosely correlated with ALDX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CANF jumps, then ALDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANF
1D Price
Change %
CANF100%
-0.96%
ALDX - CANF
46%
Loosely correlated
+1.53%
OABI - CANF
34%
Loosely correlated
+6.90%
GBIO - CANF
32%
Poorly correlated
+5.59%
IPSC - CANF
27%
Poorly correlated
+2.21%
TPST - CANF
27%
Poorly correlated
+3.33%
More